Who Owns Johnson & Johnson MedTech?
Johnson & Johnson MedTech is the medical technology segment of Johnson & Johnson (NYSE: JNJ), the healthcare company headquartered in New Brunswick, New Jersey. The segment generated $33.8 billion in 2025 sales across surgery (Ethicon), orthopaedics (DePuy Synthes), cardiovascular (Biosense Webster, Abiomed, Shockwave), and vision businesses. J&J announced in October 2025 its intent to separate DePuy Synthes into a standalone orthopaedics company, targeted for mid-2027.
Parent Company
Founded
1886
Status
Publicly Traded
Headquarters
Who Owns Johnson & Johnson MedTech?
- Parent Company: Johnson & Johnson
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: JNJ
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Johnson & Johnson MedTech | Johnson & Johnson | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
Johnson & Johnson MedTech on AmazonAdvertisement
History of Johnson & Johnson MedTech
- Founded: 1886
- Founders: Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson
Johnson & Johnson's medical technology operations trace to the company's founding in 1886 in New Brunswick, when the Johnson brothers built a business on sterile surgical dressings and sutures. Ethicon, its surgical products arm, dates to the company's early decades and became one of the world's leading surgical instrument and suture businesses.
The orthopaedics business grew through acquisition. DePuy, founded in 1895 in Warsaw, Indiana, was acquired by J&J in 1998 for $3.6 billion, then combined with Synthes, the Swiss fracture-management company, in a 2012 deal worth approximately $19.7 billion, creating DePuy Synthes as one of the world's largest orthopaedics companies.
The cardiovascular expansion accelerated in the 2010s and 2020s. J&J acquired Abiomed, the heart pump company, in 2022 for approximately $16.6 billion, then Shockwave Medical in May 2024 for approximately $13.1 billion, building a cardiovascular franchise anchored by Biosense Webster's electrophysiology business.
In 2023, the segment adopted the Johnson & Johnson MedTech name as part of the corporate rebrand that retired the historic script logo for business-facing use. That same period saw the spin-off of Kenvue, J&J's consumer health business, leaving J&J as a two-segment company: Innovative Medicine and MedTech.
Advertisement
In October 2025, J&J announced its intent to separate DePuy Synthes into a standalone orthopaedics company, appointing Namal Nawana as worldwide president of the unit. By October 2026, the company confirmed a mid-2027 target for the separation, with management favoring a spin-off to shareholders over a sale.
About Johnson & Johnson
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded on the New York Stock Exchange under the ticker symbol JNJ. The company has been publicly traded since 1944 and is one of the most widely held healthcare stocks globally, included in major stock market indices including the Dow Jones Industrial Average.
What were Johnson & Johnson's FY2025 financial results?
J&J reported full-year 2025 sales of $94.2 billion, up 6.0% year-over-year, with net earnings of $26.8 billion and adjusted EPS of $10.79. Q4 2025 sales grew 9.1% to $24.6 billion. The company generated approximately $19.7 billion in free cash flow and increased its dividend for the 63rd consecutive year.
Who is Johnson & Johnson's CEO?
Joaquin Duato serves as Chairman and CEO of Johnson & Johnson. He became CEO in 2022 and described 2025 as a "catapult year" fueled by the strongest portfolio and pipeline in the company's history. Duato has focused J&J on six key therapeutic areas: Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision.
Advertisement
What is Johnson & Johnson's 2026 outlook?
J&J issued 2026 guidance of $100.5 billion in estimated reported sales (6.7% growth at midpoint) and adjusted EPS of $11.53 (6.9% growth at midpoint). This guidance accounts for approximately $500 million in expected tariff impacts and a drug pricing agreement with the Trump administration.
What are Johnson & Johnson's main business segments?
J&J operates through two segments: Innovative Medicine (pharmaceuticals), which generated $60.4 billion in 2025 sales, and MedTech (medical devices), which contributed $33.8 billion. The company previously had a third Consumer Health segment, which was spun off as Kenvue in 2023.
What happened to Johnson & Johnson's consumer brands?
In 2023, J&J completed the spin-off of its consumer health business as Kenvue, which included Tylenol, Band-Aid, Johnson's Baby, Neutrogena, Aveeno, Listerine, and other consumer brands. Kenvue was fully separated in August 2023 via an IPO and exchange offer. These brands remain associated with J&J in public recognition.
What medical innovations did J&J achieve in 2025?
J&J secured FDA approval of CAPLYTA for major depressive disorder, approval of RYBREVANT FASPRO plus LAZCLUZE for non-small cell lung cancer, and reported landmark data for TECVAYLI plus DARZALEX FASPRO for multiple myeloma. The company also acquired Halda Therapeutics and submitted the OTTAVA Robotic Surgical System for regulatory review.
Advertisement
What is the talc litigation status?
J&J faces thousands of lawsuits alleging its talc-based baby powder caused ovarian cancer and mesothelioma. In October 2025, a California jury awarded $966 million to a mesothelioma victim's family. In March 2025, a bankruptcy judge rejected J&J's proposed $8 billion settlement for ovarian cancer claims. The litigation remains ongoing.
- Founded: 1886
- Headquarters: New Brunswick, New Jersey, USA
- Company Type: Publicly Traded
- Stock: NYSE: JNJ
- Revenue: $94.2 billion (FY2025)
- Employees: Approximately 137,000
Where Is Johnson & Johnson MedTech Made / Based?
- Headquarters: New Brunswick, New Jersey, USA
- Manufacturing / Operations: United States, Ireland, Switzerland, Germany, China, Mexico
Johnson & Johnson MedTech Categories & Tags
Brands Owned by Johnson & Johnson
Healthcare PharmaceuticalsAcuvue
Owned by Johnson & Johnson
Acuvue is the world's leading contact lens brand, owned by Johnson & Johnson Vision Care, a division of Johnson & Johnson. The brand covers daily, weekly, and monthly disposable soft contact lenses sold in more than 100 countries.
contact-lensesvision-carejohnson-and-johnson
Beauty Personal CareAveeno
Owned by Johnson & Johnson
American brand of skincare and hair care products specializing in natural ingredients and colloidal oatmeal formulations.
skincarenaturaloatmeal
Healthcare PharmaceuticalsBand-Aid
Owned by Johnson & Johnson
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Beauty Personal CareCarefree
Owned by Johnson & Johnson
American feminine hygiene brand producing panty liners and feminine care products, now owned by Essity, a Swedish global hygiene and health company.
feminine-hygienepanty-linerspersonal-care
Beauty Personal CareClean & Clear
Owned by Johnson & Johnson
American skincare brand producing facial cleansers, moisturizers, and acne treatments for teens and young women, owned by Kenvue Inc.
skincarefacial-cleanseracne-treatment
Baby CareJohnson's Baby
Owned by Johnson & Johnson
Baby care brand owned by Kenvue, offering gentle shampoo, lotion, and powder for infants worldwide since 1893.
baby-careinfant-skincareshampoo
Advertisement
Johnson & Johnson MedTech Ownership: Pros & Cons
Advantages
- +J&J's financial strength funds sustained device R&D and acquisitions
- +Diversified segment mix reduces dependence on any single device category
- +Cardiovascular acquisitions provide high-growth engines
- +Global manufacturing and hospital relationships provide unmatched distribution
- +Orthopaedics separation will sharpen segment focus on growth categories
Considerations
- -DePuy Synthes separation removes a $9.3 billion revenue base
- -Orthopedics has been the slowest-growing franchise
- -Intense competition from Medtronic and Stryker across categories
- -J&J's pharmaceutical business receives greater strategic priority
- -Surgical robotics competition from Intuitive and Medtronic pressures growth
Frequently Asked Questions About Johnson & Johnson MedTech
Advertisement
Sources & Further Reading
Competitors to Johnson & Johnson MedTech
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Becton Dickinson | USA | 1897 | Mass market | Global | All Genders | |
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Medtronic | USA | 2021 | Mass market | Global | All Genders | |
| Medtronic | USA | 1949 | Mass market | Global | All Genders | |
| Medtronic | USA | 2015 | Mass market | Global | All Genders | |
| Minimed | USA | 1983 | Mass market | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsBD
Owned by Becton, Dickinson and Company
Master brand of Becton, Dickinson and Company, the medical technology company behind Vacutainer, Pyxis, Alaris, and Bard product lines.
medical-devicesmedtechhospital-supplies
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Healthcare PharmaceuticalsHugo
Owned by Medtronic plc
Medtronic's Hugo robotic-assisted surgery system for soft-tissue procedures, FDA cleared for urologic surgery in December 2025.
surgical-roboticsmedtechmedical-devices
Healthcare PharmaceuticalsMedtronic
Owned by Medtronic plc
Flagship brand of Medtronic plc, the world's largest medical device company, covering pacemakers, heart valves, spinal implants, and surgical technology.
medical-devicesmedtechpacemakers
Healthcare PharmaceuticalsMicra
Owned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
medical-devicespacemakerscardiology
Healthcare PharmaceuticalsMiniMed
Owned by MiniMed Group, Inc.
Diabetes technology brand of MiniMed Group, the Nasdaq-listed insulin pump and CGM maker that separated from Medtronic in October 2026.
diabetesinsulin-pumpscgm
Competitive Analysis
Market Positioning: Johnson & Johnson MedTech competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Johnson & Johnson MedTech
Looking for brands with different ownership structures? These similar brands are not owned by Johnson & Johnson, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsVoraxaze
Owned by SERB Pharmaceuticals
Glucarpidase rescue therapy for toxic methotrexate levels, owned by SERB Pharmaceuticals since its 2021 acquisition of BTG.
oncologyglucarpidasemethotrexate-rescue
Privately Owned
Voraxaze is privately owned, unlike Johnson & Johnson MedTech which is under a publicly traded parent company.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsSmith+Nephew
Owned by Smith+Nephew plc
British medical technology company founded in 1856, reporting $6.16 billion in FY2025 revenue across orthopaedics, sports medicine, and advanced wound management, listed on the London Stock Exchange.
medical-devicesorthopedicswound-care
Publicly Traded
Smith+Nephew operates independently without a large parent corporation.
Healthcare PharmaceuticalsZimmer Biomet
Owned by Zimmer Biomet Holdings, Inc.
Zimmer Biomet is the flagship orthopedic brand of Zimmer Biomet Holdings, producing knee, hip, and trauma implants plus the ROSA surgical robotics platform from its Warsaw, Indiana base.
orthopedicsmedical-devicesimplants
Publicly Traded
Zimmer Biomet operates independently without a large parent corporation.
Healthcare PharmaceuticalsBoehringer Ingelheim
Owned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
pharmaceuticalsprescription-drugsanimal-health
Privately Owned
Boehringer Ingelheim is privately owned, unlike Johnson & Johnson MedTech which is under a publicly traded parent company.
Healthcare PharmaceuticalsBrainlab
Owned by Brainlab SE
Munich surgical navigation and radiotherapy software brand installed in about 4,000 hospitals worldwide.
medical-technologysurgical-navigationradiosurgery
Privately Owned
Brainlab is privately owned, unlike Johnson & Johnson MedTech which is under a publicly traded parent company.
Johnson & Johnson Stock Information
Advertisement
Jobs at Johnson & Johnson
Latest News About Johnson & Johnson MedTech
Advertisement
Related Articles About Johnson & Johnson MedTech
View more articles
Health
The Pharmaceutical Giants Behind Common Medicines
Eli Lilly is now #1 pharma ($65.2B, Mounjaro + Zepbound). Novo Nordisk has 59.6% GLP-1 share. Merck's Keytruda is $31.7B. Pfizer faces a $20B patent cliff. Discover who makes your medicines. Explore our database.
Who Brands StaffNov 6, 2026
PharmaceuticalsEli LillyNovo Nordisk
Same Company
Your Entire Medicine Cabinet Might Be J&J
Tylenol, Band-Aid, Listerine, Neutrogena, Aveeno, Benadryl. Johnson & Johnson's consumer health portfolio is extensive. Here is a complete look at the brands now under Kenvue.
Who Brands StaffApr 4, 2026
Johnson And JohnsonKenvueConsumer Health
Industry Analysis
Who Owns the Sunscreen Market
Beiersdorf owns Nivea Sun and Coppertone. L'Oreal owns La Roche-Posay and Anthelios. Edgewell owns Banana Boat and Hawaiian Tropic. Here is who controls the global sunscreen market in 2026.
Who Brands StaffMar 23, 2026
SunscreenSun CareBeauty
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandmedical-devices
Abbott Medical Devices
Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.
Brand in Healthcare & Pharmaceuticals
cardiovasculardiabetes-care
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization